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ABSTRACT
The Rpb4 and Rpb7 subunits of eukaryotic RNA poly-
merase II (RNAPII) form a heterodimer that protrudes
from the 10-subunit core of the enzyme. We have
10 obtained crystals of the human Rpb4/Rpb7 hetero-
dimer and determined the structure to 2.7A ˚ resolu-
tion. The presence of putative RNA-binding domains
on the Rpb7 subunit and the position of the hetero-
dimer close to the RNA exit groove in the 12 subunit
15 yeast polymerase complex strongly suggests a role
for the heterodimer in binding and stabilizing the
nascent RNA transcript. We have complemented the
structural analysis with biochemical studies direc-
ted at dissecting the RNA-binding properties of the
20 human Rpb4/Rpb7 complex and that of the homo-
logous E/F complex from Methanocaldococcus
jannaschii. A number of conserved, solvent-
exposed residues in both the human Rpb7 subunit
and the archaeal E subunit have been modified by
25 site-directed mutagenesis and the mutants tested
for RNA binding by performing electrophoretic
mobility shift assays. These studies have identified
an elongated surface region on the corresponding
face of both subunit E and Rpb7 that is involved
30 in RNA binding. The area spans the nucleic acid
binding face of the OB fold, including the B4–B5
loop,butalsoextendstowardstheN-terminaldomain.
INTRODUCTION
In the eukaryotic RNA polymerase II (RNAPII), two subunits
35 (Rpb4/Rpb7) form a heterodimer that associate with the 10-
subunit core of the enzyme (1). The stoichiometry of RNAPII
puriﬁed from Saccharomyces cerevisiae cells is dependent on
growth conditions: in optimally growing cells only  20% of
puriﬁed material includes the Rpb4/Rpb7 heterodimer, while
40 in the post-log phase virtually all the polymerase molecules
contain the 12 subunits. RNAPII puriﬁed from rpb4D cells not
only lacks the corresponding subunit Rpb4, but also contains
no detectable Rpb7 (2). Whereas in S.cerevisiae RPB7 is an
essential gene, RPB4 is dispensable under optimal growth
45 conditions, but becomes essential during heat or cold shock,
and under nutrient depletion. Overexpression of Rpb7 partly
compensates for the rpb4D stress phenotypes and Rpb7 can
interact with RNAPII independently of Rpb4, although this
interaction is not very stable and can only be detected when
50 the subunit is overexpressed (3,4). In the S.cerevisiae system,
Rpb4/Rpb7 is necessary for promoter-directed transcription
initiation but dispensable for transcription elongation and ter-
mination in vitro (2) and activated transcription in vivo (5).
Rpb4 also recruits the CTD phosphatase Fcp1 (6). Both Rpb4
55 and Rpb7 have been shown to have additional speciﬁc func-
tions in gene expression, such as regulating transcription-
coupled repair through the Rad26-dependent pathway (7), in
efﬁcient mRNA export (8)and in transcription termination(9).
The heterodimer seems therefore to play a role in the intricate
60 network linking transcription, RNA processing and mRNA
export.
Archaea contain a single RNAP enzyme with subunits
which show considerable sequence homology to the subunits
of the eukaryotic RNAPII. The sequences of the Rpb7 sub-
65 units from eukaryotes and the homologous E subunits from
archaea are well conserved while the sequence similarity
between the eukaryotic Rpb4 subunits and the archaeal F
subunits is very much lower (Figure 1). The archaeal RNAP
is fully capable of promoter-directed transcription without
70 subunits E/F (10). It is interesting to note that the stimulatory
effect of the archaeal basal transcription factor TFE (homo-
logous to eukaryotic TFIIEa) is dependent on the RNAP sub-
units E/F, also suggesting a role of E/F for transcription
initiation in the archaea (11).
75 Since the heterogeneity in the yeast polymerase prepara-
tions caused by the variable stoichiometry of the Rpb4/Rpb7
heterodimer interfered with crystallization, crystals of RNAPII
diffracting to high resolution were originally obtained for the
10-subunit core (12). However, the 3D structure of the com-
80 plex between the archaeal homologues of E and F had been
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doi:10.1093/nar/gki945determined by crystallography at 1.75 s resolution (13). The
crystal structure of the 12-subunit yeast RNAPII complex was
initially determined at 4.2 s resolution (14,15). As the low-
resolution map did not allow an independent atomic model to
5 be built for the eukaryotic Rpb4/Rpb7 complex, the structure
of the archaeal E/F dimer was simply placed into the electron
density. More recently the crystal structure of the S.cerevisiae
Rpb4/Rpb7 complex has been determined (16), which has
allowed the 12-subunit RNAPII complex to be reﬁned to
10 3.8 s resolution.
The archaeal subunit E (the Rpb7 homologue) has an
elongated two-domain structure, containing two potential
single-stranded RNA (ssRNA)-binding motifs: a truncated
RNP motif at the N-terminus and a S1 motif at the
15 C-terminus (13). The presence of an S1 motif in the sequence
and structure suggests that its role is to bind single-stranded
nucleic acids. Indeed, the eukaryotic Rpb4/Rpb7 complex has
been shown to bind to both single-stranded DNA (ssDNA) and
ssRNA with comparable afﬁnities (17). Although proteins
20 containing an OB fold can bind either ssRNA or ssDNA,
the particular subgroup containing the sequence signature
of the S1 motif bind ssRNA without sequence speciﬁcity.
We therefore proposed a model for the function of the
heterodimer, in which the S1 motif of Rpb7 interacts with
25 the nascent RNA transcript, possibly assisted by the truncated
RNP domain (13).
We have now determined the crystal structure of the human
Rpb4/Rpb7 complex. To gain insight into the contributions of
different regions of the heterodimer to RNA binding, we have
30 carried out structure-based mutational analysis of conserved,
surface-exposed amino acid residues in both the archaeal E/F
and the human Rpb4/Rpb7 protein complex and tested the
ability of each mutant protein to bind RNA. We show that
residues within an elongated patch on the surface of human
35 Rpb7 contribute to RNA binding. The RNA-binding region
includes residues forming the OB fold in the C-terminal
domain of the protein as well as additional residues from the
N-terminal domain. In the context of the yeast 12-subunit
RNAPII complex, the RNA-binding region of human Rpb4/
40 Rpb7 corresponds to the face of the heterodimer adjacent to
the 10-subunit core. We also show that, in spite of relatively
weak sequence identity, residues within a surface patch in a
corresponding position on the surface of subunit E of the
archaeal polymerase also contribute to RNA binding.
Figure 1. StructurebasedsequencealignmentoftheRpb4andRpb7subunits.Sequencesofthehuman(HS),yeast(SC)andM.jannaschii(MJ)orthologuesofRpb4
and Rpb7 are included. The secondary structure of the human protein determined using DSSP (33) is indicated above the sequences while secondary structural
elements in the yeast (PDB entry 1y14) and M.jannaschii (PDB entry 1go3) proteins are indicated by boxes. Amino acids not present in the high-resolution crystal
structures are indicated by italics. Residues which are well conserved in archaeal and eukaryotic sequences are highlighted using a green background. In the Rpb7
alignment,aredbackgroundindicatesresiduesmutagenizedinthisstudywhichhaveastrongeffectontheRNA-bindingpropertiesoftheproteinwhereasanorange
background indicates residues whose mutation has a weaker effect on RNA binding. Residues in strands B1–B6 of Rpb7 share sequence similarity with proteins
containing an S1 motif and form a b-barrel structure called an OB fold.
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Expression, purification and crystallization of human
Rpb4/Rpb7
Co-expression in Escherichia coli of the human Rpb4/Rpb7
5 complex was achieved by using a bicistronic construct based
upon pGEX-2TK (Amersham Biosciences) in which the Rpb4
subunit was fused to a glutathione-S-transferase tag that was
cleavable by thrombin, whereas the Rpb7 subunit was
expressed as an untagged protein (18). E.coli BL21(DE3)
10 cells were transformed under the control of ampicillin and,
after induction at OD600 between 0.6 and 0.9, cell cultures
were grown at 28 C overnight. The cells were harvested by
centrifugation and resuspended in 20 mM Tris–HCl, pH 7.9,
300 mM potassium acetate, 7 mM magnesium acetate, 1 mM
15 EDTA, 10 mM DTT, 10% glycerol (buffer P300), supplemen-
ted with lysozymeat1mg/ml,Benzonase(0.1U/ml)and 1mM
4-(2-aminoethyl)benzenesulphonyl ﬂuoride. Cell lysis was
performed by sonication and the resulting lysate clariﬁed by
centrifugation and ﬁltration. All the chromatographic steps
20 were performed at 4 C. The crude extract was bound in
batch to glutathione sepharose beads (Amersham Biosciences)
and the beads were extensively washed with buffer P300. The
protein was recovered from the beads by cleavage with throm-
bin overnight at 4 C. In preparation for anion exchange chro-
25 matography, the supernatant was dialyzed against buffer A
[20 mM Tris–HCl, pH 8.0, 1 mM EDTA, 10% glycerol and
10 mM b-mercaptoethanol] containing 100 mM NaCl. The
dialyzed protein solution was loaded onto a Resource Q col-
umn (Amersham Biosciences) using an A ¨KTA FPLC appar-
30 atus (Amersham Biosciences) and eluted with a linear gradient
from100mMto1MNaClinbufferA.Afterconcentration,the
sample was applied to a Superdex-200 10/30 gel ﬁltration
column (Amersham Biosciences) equilibrated with 20 mM
MES, pH 6.5 and 100 mM NaCl. Pooled peak fractions
35 were ﬂash frozen in liquid nitrogen and stored at  80 C
until further use.
For crystallization the protein was concentrated to 15 mg/ml
in 20 mM PIPES, pH 6.8, 100 mM NaCl and 15%
glycerol. Crystals were grown at 18 C by vapour diffusion
40 in hanging drops, against a well solution containing 100 mM
PIPES pH 7.4, 25% polyethylene glycol (MW 4000) and 15%
glycerol. Most of the crystals grew as clusters of thin plates,
but occasionally a few small chunky crystals could be
obtained.
45 Structure determination and refinement
The crystals were ﬂash-frozen directly from the drop and
X-ray data collected at 100 K using a MAR image plate
detector mounted on a Rigaku RU-H3R rotating anode
X-ray generator equipped with OSMIC focusing mirrors
50 (CuKa radiation; l ¼ 1.54 s). The diffraction data were pro-
cessed with MOSFLM and programs of the CCP4 suite (19).
The crystals are in space group P1 with four heterodimers in
the asymmetric unit (Table 1). A search model for molecular
replacement was constructed from the yeast Rpb4/Rpb7 com-
55 plex (29% sequence identity for Rpb4, 37% sequence identity
for Rpb7) (16). The positions of the four copies of the hetero-
dimer in the asymmetric unit were determined with the pro-
gram PHASER (20), and alternating cycles of reﬁnement with
CNS (21) and model building with O (22) resulted in the ﬁnal
60 model. The four copies of the Rpb7 subunit make different
crystal contacts and adopt two slightly different conforma-
tions. The largest differences are located in the A1–K2 and
the A3–A4 loops (Figures 1 and 2) with residues 60–63 dif-
fering in position by >5 s. Tight restraints between pairs of
65 heterodimers were applied during the reﬁnement procedure.
The reﬁned model has 98.9% of the residues in allowed or
additionally allowed regions of the Ramachandran plot and no
residues in disallowed regions. Residue 172 of Rpb7 and resi-
dues 1–13 and 142 of Rpb4 have no electron density and are
70 presumed disordered. Crystallographic statistics are summar-
ized in Table 1. The coordinates have been deposited in the
Protein Data Bank (entry 2C35).
Expression and purification of the wild-type
and mutant protein for RNA binding
75 The wild-type human Rpb4/Rpb7 complex was expressed and
puriﬁed as described above. For expression of the Methano-
caldococcus jannaschii heterodimer, subunits E and F were
subcloned generating a bicistronic expression construct in
pET21a(+) (Novagen) and co-expressed as untagged proteins
80 in BL21(DE3) cells by inducing exponentially growing cells
with 0.5 mM Isopropyl-b-D-thiogalactopyranoside for 3–5 h at
37 C. Cells were lysed in P300 as described above and the
lysate held at 75 C for 40 min. The thermally denatured E.coli
proteins were removed by centrifugation and the supernatant
85 incubated with DEAE-sepharose in order to remove nucleic
acids. The resulting lysate preparation was loaded onto a
HiLoad Superdex-75 26/60 gel ﬁltration column (Amersham
Biosciences) and equilibrated with 20 mM Tris–HCl, pH 8.0
and 100 mM NaCl. Pooled peak fractions were concentrated
90 to between 10 and 15 mg/ml, ﬂash frozen in liquid nitrogen
and stored at  80 C.
Site-directed mutagenesis was performed using the
QuikChange (Stratagene) mutagenesis kit according to the
manufacturer’s instructions. After conﬁrmation of each muta-
95 tion by sequencing, the M.jannaschii and human complexes
were expressed in E.coli as described above and puriﬁed fol-
lowing essentially the same strategy as used for the corres-
ponding wild-type proteins, with the exception that the anion
exchange chromatography step was omitted in the puriﬁcation
100 of the human Rpb4/7 mutants.
Table 1. Data collection and refinement statistics
Space group P1
Cell parameters (A ˚) a ¼ 45.69, b ¼ 83.19, c ¼ 99.31,
a ¼ 85.53 , b ¼ 81.80 , g ¼ 81.77 
Resolution (A ˚) 43.3–2.7 (2.85–2.7)
Rmerge (%) 6.9 (39.4)
Multiplicity 3.4 (3.4)
Completeness (%) 95.3 (93.8)
I/s 14.5 (3.4)
Rwork (%) 23.1
Rfree (%) 26.6
R.m.s.d. bonds (A ˚) 0.008
R.m.s.d. angles (degrees) 1.4
Number of protein atoms 9236
Number of water molecules 54
Highest resolution shell values shown in parentheses.
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The probe template was a gift from S. Curry (Imperial
College) and directs transcription in pGEM4Z (Promega) of
a 54-ribonucleotide RNA species. The RNA probe was pro-
5 duced by in vitro transcription using T7 RNA polymerase and
32P-UTP according to standard procedures. Following tran-
scription, the template was digested with 1 U of RNase-free
DNase I and unincorporated nucleotides removed using a
MicroSpin G-25 desalting column (Amersham Biosciences);
10 the RNA was recovered by precipitation with 1 vol of 7.5 M
NH4OAc and 4 vol of ethanol. Probe at a concentration of
2500 c.p.m. was used in a 10 ml reaction containing 10 mM
MOPS, pH 6.8, 100 mM NaCl, 10% glycerol, 40 U of RNasin
(Promega) and varying amounts of protein. The samples were
15 incubated at room temperature for 15 min before loading onto
a native 4–20% acrylamide (Novex), 0.5· TBE gel. The com-
plexes were separated electrophoretically on 4–20% TBE gels
(Invitrogen) at 100 V for 2.5 h at 4 C and quantiﬁed using a
phosphorimager (Fuji).
20 RESULTS
Crystalstructure ofthehumanRpb4/Rpb7heterodimer
The human Rpb4/Rpb7 complex crystallizes with four copies
of the heterodimer in the crystallographic asymmetric unit.
The structure was solved at 2.7 s resolution by molecular
25 replacement using the yeast Rpb4/Rpb7 complex as a search
model (16) and reﬁned to a free R-factor of 26.6% (working
R-factor of 23.1%) with good geometry (for more statistics see
Table 1).
The Rpb7 polypeptide folds into two separate domains
30 forminganelongatedstructure(Figure 2,blue).Thesixhelices
of Rpb4 (Figure 2, pink) pack around the central region
of Rpb7 at the interface between the two domains. The
N-terminal domain of Rpb7 (lower blue domain in Figure 2)
folds into a four-stranded anti-parallel b-sheet (strands A1–
35 A4) that wraps around an a-helix (K2). An additional ﬁfth
strand of this b-sheet (strand A10) is formed from residues
near the N-terminus of Rpb4. The C-terminal domain of
Rpb7 folds into a b-barrel structure known as an OB fold
(strands B1–B6) which is capped by a small 3-stranded
40 antiparallel b-sheet (strands C1–C3).
As expected, the structure of the human Rpb4/Rpb7 het-
erodimer is similar to the yeast and M.jannaschii orthologues
(Figure 2). Optimally superimposition of the human Rpb4/
Rpb7 heterodimer onto the yeast heterodimer in the
45 12-subunit RNAPII complex obtained at 3.8 s (PDB entry
1wcm) results in 282 equivalent Ca atoms that are within
4 s (r.m.s. separation of 0.66 s). A similar superposition
onto the higher resolution (2.3 s) but less complete crystal
structure of the isolated yeast heterodimer (PDB entry 1y14)
50 results in 249 Ca atoms within 4 s (rmsd 0.61 s). Superposi-
tion onto the archaeal heterodimer (PDB entry 1go3) results in
252 equivalent Ca atoms that are within 4 s (rmsd of 0.99 s).
The archaeal E/F and the human Rpb4/Rpb7
heterodimers bind RNA with comparable affinities
55 To test for ssRNA-binding activity, we performed electro-
phoretic mobility shift assays (EMSA). The archaeal E/F
heterodimer was incubated with a radiolabelled RNA probe
Figure 2. Structures of the M.jannaschii E/F complex (PDB entry 1go3), yeast Rpb4/Rpb7 complex (PDB entry 1wcm) and human Rpb4/Rpb7 complex. The
complexesareviewedfromthesideoftheheterodimerwhichfacestheRNAexitgrooveoftheRNAPIIcore.ThestructurallyconservedregionsoftheRpb4subunits
arecolouredpinkwhilethestructurallyconservedregionsoftheRpb7subunitsarecolouredviolet.IntheM.jannaschiicrystalstructurenoelectrondensityisvisible
fortheloopconnectingstrandsB4andB5;thisloophasbeendrawnforthesakeofclarityandiscolouredindarkblue.Regionsoftheyeastandarchaealstructuresthat
differ from the human protein are shown in grey. The yeast structure is from the 12-subunit RNAPII complex obtained at 3.8 s (PDB entry 1wcm) rather than the
higher resolution but less complete structure of the isolated heterodimer. This figure and all others representing molecular structures were generated with PyMOL
(http://pymol.sourceforge.net).
6438 Nucleic Acids Research, 2005, Vol. 33, No. 19using increasing protein concentrations (25 ng to 10 mg) and
the mixture analysed by PAGE (Figure 3A) to monitor the
formation of protein–RNA complexes. A quantitative analysis
of the RNA binding gave a value of 540 nM for the dissoci-
5 ation constant (Figure 3B). A similar procedure was carried
out with the recombinant human Rpb4/Rpb7 heterodimer and
gave an RNA dissociation constant of 420 nM (Figure 3C
and D). Protein–RNA complexes with comparable afﬁnities
were obtained using various RNA probes (data not shown)
10 indicating that the binding is not sequence speciﬁc.
Dissecting the RNA-binding region in the
archaeal E/F complex
To identify the RNA-binding surface of the M.jannaschii E/F
complex we mutated residues of the E subunit, tested the
15 RNA-binding properties of the mutant protein by a gel-shift
assay and compared the binding with the wild-type protein.
Targets for the mutagenesis were selected based on their
surface-exposure (in the context of RNAPII), amino acid con-
servation (in the archaeal domain) and chemical nature.
20 Because we expected a reasonably large interaction area
between protein and nucleic acid, we reasoned that substitu-
tion of one of the contact residues to alanine was probable to
have a minor effect on RNA binding owing to the large num-
ber of remaining interactions stabilizing the complex. We
25 therefore opted for charge-reversal substitutions which are
more probable to disrupt the interaction.
The atomic model of the E subunit shows the presence of
twodistinctdomainsforminganelongatedstructure(Figure2).
The sequence of the C-terminal domain (Figure 2, upper blue
30 domain) indicated the presence of a S1 motif (Figure 1, strands
B1–B6). The S1 motif folds into the b-barrel structure which
characterizes OB folds. A cluster of conserved surface-
exposed amino acids is located on the exposed face of the
b-barrel, and includes charged or polar residues (Asp105,
35 His109, Ser111, Gln112, Lys152 and Lys160) and aromatic
residues (Phe95 and Phe98) (Figure 4). To determine whether
anyofthesesurfaceresidueswerefunctionallyimportant,each
of them was replaced byeither a reverse-charge mutation or by
alanine. In some OB folds, the loop connecting strand B4 and
40 B5 has been shown to play a central role in DNA or RNA
Figure 3. EMSAsusingRNAPsubunitsE/FfromM.jannaschiiandhumanRpb4/Rpb7.ArchaealE/FandhumanRpb4/7giverisetocomplexeswiththeRNAprobe
in a protein-concentration dependent manner. Asterisks indicate the position of the free probe, while double asterisks indicate the position of the protein–RNA
complexes. The protein concentrations were 25 ng, 50 ng, 100 ng, 250 ng, 500 ng, 1 mg, 2 mg, 3.5 mg, 5 mg, 7.5 mg and 10 mg. (A) Lane 1, free probe; lanes 2–12:
increasingconcentrationofM.jannaschiiE/Fcomplex.(B)QuantificationoftheEMSAexperimentfortheM.jannaschiicomplexhasbeencarriedoutbyplottingthe
fractionaloccupancyoftheprobeboundtotheprotein,correctedforthebackground,againsttheproteinconcentration(C)Lane1,freeprobe;lanes2–10:increasing
concentration of human Rpb4/Rpb7 complex. (D) Quantification of the EMSA experiment for the human complex has been carried out as described in (B).
Nucleic Acids Research, 2005, Vol. 33, No. 19 6439binding by closing over the nucleic acids. The sequence of the
loop in M.jannaschii includes four positively charged residues
and is disordered in the crystal structure. To examine the role
of the B4–B5 loop in nucleic acid binding, we have created a
5 ‘loop mutant’ in which Arg155, Lys156 and Arg157 were
mutate to alanine, serine and alanine, respectively. Based
on the same criteria of surface exposure and sequence con-
servation, a further set of residues were identiﬁed in the
N-terminal domain of the E subunit, which folds into a trun-
10 cated RNP domain. These comprised Lys33, Arg37, Lys40
and Asp41.
Figure 4 shows the position of the mutated residues on the
crystal structure of the M.jannaschii E/F complex. The expres-
sion levels and purity of the mutants were comparable with
15 that of the wild-type protein. Moreover, all mutants were
thermostable (75 C) and behaved in a similar manner to the
wild-type heterodimer on gel ﬁltration, demonstrating that the
structural integrity of the mutant E/F complexes were not
compromised by the amino-acid substitutions. The two excep-
20 tions were the mutants involving Lys40 and Asp41, which
could not be puriﬁed to the same standards and were therefore
not tested for binding. The RNA-binding properties of the
mutants were then compared with those of the wild-type pro-
tein. Examples of RNA-binding experiments for a selection of
25 mutants are reported in Figure 5A and B, while all the results
are summarized in Figure 5C.
While mutation of Phe95, Phe98 and Ser111 only mildly
affect the interaction with the nucleic acids, most of the
mutants showed a decrease in RNA binding when compared
30 with the wild-type protein. The loop mutant, as well as muta-
tion of a number of positively charged residues (Lys33, Arg37,
Lys152 and Lys160), virtually abolish RNA binding. When
the residues whose mutation has have a strong effect in
the interaction are displayed on the crystal structure of the
35 M.jannaschii E/F heterodimer (Figure 4), a putative RNA-
binding path emerges involving both the N-terminal and
C-terminal domains.
Dissecting the RNA-binding region in the
human Rpb4/Rpb7 complex
40 We applied a similar approach to study the RNA-binding
properties of the human Rpb4/Rpb7 complex. The sequence
identity between subunit E and Rpb7 is only  21% of the
amino acids that are conserved in the S1 motif of the archaeal
homologue, only Phe 98 is also well conserved in the euka-
45 ryotic homologues. However, a similar pattern of exposed,
conserved residues in the C-terminal domain of the eukaryotic
Rpb7 subunits can be inferred. These residues include Thr90,
Asn93, Lys94, Phe98, Phe107, Ser109, His111, Arg151,
Asp153 and Phe158. Another set of conserved, surface-
50 exposed residues can be found in the N-terminal domain,
comprising His14, Glu33 and Lys41. These residues were
mutated to either alanine, lysine or glutamic acid and are
shown on Figure 4.
As was the case with the E/F mutant complexes described
55 above, the expression levels and purity of the human Rpb4/
Rpb7 mutants were comparable with the wild-type protein.
Unfortunatelywehave been unabletoexpress anyproteinwith
a mutation at position 98; attempts to change the phenylalan-
ine residue to either alanine or glutamic acid seriously affected
60 the solubility of the protein. The RNA-binding properties of
the mutants were then compared with those of the wild-type
protein. ExamplesofRNA-bindingexperiments foraselection
of mutants are reported in Figure 5D and E, while all the
results are summarized in Figure 5F.
65 As in the archaeal protein, residues can be classiﬁed into
two categories, based on the impact of the mutation on the
RNA-binding properties. Thr90, Asn93, Lys94 and Phe107
decrease the binding by about a factor of two, while the
other residues have a stronger impact on the interaction.
70 When the residues which have a strong effect are displayed
on the crystal structure of the human Rpb4/Rpb7 heterodimer,
a pattern similar to that observed in the archaeal system
emerges, with the putative RNA-binding path spanning both
domains of the Rpb7 subunit.
75 DISCUSSION
In the yeast 12-subunit RNAPII complex, the Rpb4/Rpb7 het-
erodimer is positioned with the Rpb7 subunit orientated
towards the 10-subunit core so that the Rpb4 helices are on
the outside of the complex (Figure 6) (16). The large insertion
80 between helices H1 and H2 in yeast Rpb4 is therefore posi-
tionedontheouterfaceofthepolymerasemolecule,wellaway
from the core subunits. However, the very variable N-terminal
segment of Rpb4 is in close proximity to the polymerase
core. The 13 N-terminal amino acids of human Rpb4 are
85 not conserved in eukaryotes and are disordered in the crystal
structure. In contrast, the solvent exposed Glu14 and Glu15 in
Figure 4. Ribbondiagramsshowingthepositionoftheresiduesmutatedinthis
study onthe crystalstructuresofM.jannaschiisubunitE andhumanRpb7.The
subunits are viewed in the same orientation as that used in Figure2. The amino
acid side chains whose mutations have a large effect on the RNA-binding
properties of the complex are shown in red, while the amino acids that have
a weaker effect are shown in orange.
6440 Nucleic Acids Research, 2005, Vol. 33, No. 19the human structure (residues 21 and 22 in yeast, Figure 1)
are well conserved and residues 14–28 at the N-terminus
of the human Rpb4 overlap with the corresponding residues
(21–35) of the yeast structure. The conformation of this loop is
5 probable to be conserved in eukaryotes as it is stabilized by
the interactions of conserved hydrophobic side chains:
Phe23 and Phe26 of Rpb4 pack against Phe95 of Rpb4 and
Phe80 of Rpb7. In the crystal structure of the human protein,
the loop is directly followed by strand A10 in which the poly-
10 peptide chain forms hydrogen bonds with strand A1 of the
Rpb7 subunit. The yeast Rpb4 sequence has a 11-residue
insertion at this position (residues 36–46) that folds to
form a pair of short antiparallel b-strands before entering
strand A10.
15 In the structure of the 12-subunit yeast polymerase, the loop
between strands A3 and A4 of Rpb7 (the ‘tip loop’) contacts
the core subunits of the polymerase. This loop region appears
to be ﬂexible as it is disordered in the high-resolution yeast
crystal structure (16) and adopts slightly different conforma-
20 tions in the different copies of the Rpb7 subunit within the
crystallographic asymmetric units of both the archaeal and
human structures.
The S1 motif, present in the C-terminal domain of the
E subunits, is found in a number of other proteins including
25 bacterial and eukaryotic translation initiation factors, proteins
involved in mRNA degradation, proteins involved in mRNA
release from the spliceosome as well as bacterial transcription
factors. Some of these proteins have been shown to bind
Figure 5. Results of EMSAs performed using a radiolabelled RNA probe. (A) Example of a mobility assay using the M.jannaschii E/F heterodimer. Lane 1, free
probe;lanes2–8,increasingconcentrationsoftheE/FcomplexwithaF95AmutationintheEsubunit;lanes10–15,increasingconcentrationsoftheE/Fcomplexwith
aD105KmutationintheEsubunit.(B)ExampleofamobilityassayusingtheM.jannaschiiE/Fheterodimer.Lane1,freeprobe;lanes2-8,increasingconcentrations
of the E/F complex with a Q112K mutation in the E subunit; lanes 10–15, increasing concentrations of the E/F complex with the Dloop mutation in the E subunit.
(C)Summaryoftheeffectofmutationsin the M.jannaschiiEsubunitonthe RNA-bindingproperties.Foreach mutantprotein,the percentage ofRNAprobebound
to the protein, after background correction, is shown. (D) Example of a mobility assay performed using the human Rpb4/Rpb7 heterodimer. Lane 1, free probe;
lanes 2–7, increasing concentrations of wild-type Rpb4/Rpb7 (ranging from 125 ng to 10 mg); lanes 9–14, increasing concentrations of Rpb4/Rpb7 with a H14E
mutationin Rpb7. (E) Exampleof a mobility assay performedusing the humanRpb4/Rpb7 heterodimer. Lane 1, free probe;lanes 2-8, increasingconcentrationsof
Rpb4/Rpb7 with a D153K mutation in Rpb7; lanes 10–15, increasing concentrations of Rpb4/Rpb7 with a F158A mutation in Rpb7. (F) Summary of the effect of
mutations in the human Rpb7 subunit on the RNA-binding properties, where experimental data were treated as described for the M.jannaschii E subunit.
Nucleic Acids Research, 2005, Vol. 33, No. 19 6441ssRNA in vitro. Despite a high degree of sequence similarity,
no residue is absolutely conserved throughout the entire motif.
From a structural viewpoint, the motif folds into a 5-stranded
b-barrel known as OB fold, a common and ubiquitous struc-
5 tural motif, with no conserved sequence pattern, often
involved in oligonucleotide binding. To date, no direct struc-
tural information is available on the interaction of S1 domains
with nucleic acids, but the structures of several OB folds have
been determined in the presence of RNA or DNA (23).
10 Although the speciﬁc details of the interactions differ, in all
these proteins oligonucleotide binding occurs on the face of
the barrel containing the conserved residues in the S1 motif.
Gel mobility shift assays have conﬁrmed that the yeast
Rpb4/Rpb7 heterodimer binds single-stranded nucleic acid,
15 with an apparent dissociation constant of 0.7 mM for DNA
and 1.2 mM for RNA (17). We have subsequently demon-
strated that both the archaeal E/F complex and the yeast
A14/A43 complex (its homologue in RNAPI) are able to
bind nucleic acid with comparable afﬁnities (24). This indic-
20 ates that the RNA-binding function is evolutionary conserved
in the archaeal and eukaryotic RNA polymerases. We have
now quantiﬁed the binding of RNA to both the archaeal E/F
heterodimer and the human Rpb4/Rpb7 heterodimer and in
both cases determined a dissociation constant of 400–500 nM.
25 This relatively low-binding afﬁnity is consistent with the pro-
posedroleofthe complexinthe non-speciﬁc, transient binding
of the newly synthesized RNA transcript. We have used the
structure of both the archaeal M.jannaschii E/F complex and
thehumanRpb4/Rpb7complextoidentifyresiduespotentially
30 important for RNA recognition.
In the crystal structure of the M.jannaschii subunit, no elec-
tron density is visible for part of the loop connecting strand B4
and B5. In a number of OB folds this loop has been shown to
play a central role in DNA or RNA binding (using arginine,
35 serine and lysine residues to interact with the sugar-phosphate
backbone) and often undergoes a conformational change to
trap the nucleic acid (23). The sequence of the loop in
M.jannaschii includes four positively charged residues that
may play a role in non-sequence-speciﬁc nucleic acid binding.
40 Although the type and order of these residues are not con-
served in archaeal sequences, charged and polar residues are
usually present. We have created a triple mutant in the
E subunit, in which three positively charged residues
(Arg155, Lys156 and Arg157) were eliminated. The mutation
45 of the loop has a remarkable effect, completely abolishing
RNA binding. Mutating two adjacent positively charged resi-
dues (Lys152 and Lys160) to glutamic acids also completely
abolishes RNA binding. In the human Rpb7 sequence the loop
is shorter, but mutation of the surrounding residues (Arg151,
50 Asp153 and Phe158) also nearly abolish RNA binding, con-
ﬁrming the importance of this region in protein–nucleic acid
interaction.
In deletion mutagenesis studies of S.cerevisiae Rpb7 (17), a
mutant lacking the B4–B5 loop was shown to retain nucleic
55 acid binding but was found to be inactive in transcription.
Mutants inthis earlier studywere designed based on the homo-
logy to the S1 motif, without knowledge of the actual struc-
ture. The B4–B5 loop deletion (residues 151–158) included
part of b-strands B4 and B5, but the fact that such deletion had
60 no effect on nucleic acid binding may be correlated to the lack
of positively charged residues in this region of the yeast
sequence.
The S1 motif in the C-terminal domain of subunit E was the
primary candidate for mutagenesis studies. However, the topo-
65 logy of the N-terminal domain of subunit E/Rpb7 resembles a
‘truncated’, non-canonical RNP fold. RNP domains are the
most widely found and best characterized ssRNA-binding
motifs and fold into a b1 a1 b2 b3 a2 b4 structure,
with the four antiparallel b-strands packing against the two
70 helices. A truncated RNP motif, lacking a2 and b4, is present
in the structure, and resembles most closely the anticodon-
binding domain of phenylalanine tRNA synthetase (25). How-
ever it was not clear whether this was simply a structural
module, or whether it may be involved in RNA binding.
75 When the criteria for mutagenesis were applied to the
N-terminal domain, only a handful of residues for mutagenesis
could be identiﬁed. A number of well-conserved residues are
locatedon twoloopsatthe bottomofthisdomain(loopA1–K2
and A3–A4; Figure 2), including a number of proline and
80 glycine residues, as well as hydrophobic amino acids. How-
ever the crystal structure of the 12-subunit complex shows
that these loops are involved in the interaction with the
RNAP core, in particular with helix 1 of Rpb6, three short
regions of Rpb1 (including the N-terminus and the linker
85 leading to the CTD) and the anchor region of Rpb2 (16).
The conserved residues are therefore not available for RNA
binding within the polymerase context, and have not there-
fore been tested. No reasonably conserved, surface-exposed
residue could be identiﬁed on the canonical RNA-binding
90 surface of the RNP domain. However, a few residues that
fulﬁlled the criteria for mutagenesis were found on the face
of the RNP domain which includes helix K2, and were shown
to have an effect on RNA binding.
Figure6.Ribbondiagramshowingthelocationofthemutationsandtheireffect
on RNA binding, within the context of the RNAPII. The crystal structure of the
entire 12-subunits RNAPII from yeast (PDB entry: 1wcm) is shown, with the
10 core subunits colour-coded as in Cramer et al. (12). The Rpb4 and Rpb7
subunitsareshownontheleftinpinkandblue,respectively.Theyeastresidues
structurally equivalent to the residues that have been mutated in the human
Rpb7 are shown in red and yellow. As in Figure 4, residues that have a strong
effect on RNA binding are shown in red, while orange indicates residues that
have a weaker effect on binding.
6442 Nucleic Acids Research, 2005, Vol. 33, No. 19When the residues that are involved in RNA binding are
plotted on the crystal structures of the archaeal and the human
heterodimers, a similar pattern emerges, with residues located
in similar positions having comparable effects on the interac-
5 tion with nucleic acids, even when the chemical nature of the
residues differ. The RNA-binding residues are clustered along
the vertical axis of the elongated Rpb7/E subunit, spanning the
length of the molecule from the N-terminal to the C-terminal
domain. Within the OB fold, the residues that have the stron-
10 gest impact on RNA binding are located on strands B3, B4 and
B5 of the b-barrel.
In summary, combining structural information with muta-
tional analysis and EMSAs on both the archaeal E subunit and
the eukaryotic Rpb7 subunit, we have identiﬁed a putative
15 RNA-binding path along the surface of the Rpb7/E subunit.
Most of the residues that have an impact on RNA binding are
located on the canonical nucleic acid binding face of the OB
fold.Interestingly,theresiduescontributingtoRNAbindingin
the N-terminal domain are not situated on the front surface of
20 the b-sheet of the truncated RNP domain, the surface normally
involved in nucleic acid binding.
Recent results have shown that yeast Rpb7 can be
UV-crosslinked in a strong and reproducible manner to
both strands of promoter DNA, between the TATA box and
25 the start site (26), suggesting that in addition to its function in
binding and stabilizing the nascent RNA, Rpb7 has an addi-
tional DNA-binding function during transcription initiation.
In this scenario, it is possible that the RNA-binding surface we
have identiﬁed is also involved in binding DNA during the
30 initiation stage.
The human Rpb7 has been shown to interact with a number
of transcription factors, some of which are involved in cancer
development. Human Rpb7 interacts with the Ewings Sarcoma
oncogene DNA-binding domain (27–29) and with the Nepho-
35 blastoma Overexpressed proto-oncogene, which in non-
malignant cells is probably involved in the differentiation
of several cell types (30). The retinoic acid receptor has
been shown to bind to Rpb7 in its unliganded form and repress
transcription of a number of transcriptional activators, such as
40 AP-1 (31). Human Rpb7 has also been identiﬁed as a target of
the von Hippel-Lindau protein, a component of a ubiquitin
ligase E3 complex that acts as potent tumour suppressor and
regulates the transcription and secretion of the vascular
endothelial growth factor (32). All these data suggest that
45 Rpb4/Rpb7 may mediate the interaction between a number
of enhancer transcription factors and the RNA-polymerase
core, to regulate gene expression. A high-resolution model
of the human complex provides a structural framework to
understand the multiple interactions between oncogenic tran-
50 scription factors and Rpb7.
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